As artificial intelligence (AI) permeates clinical trial operations more than ever, workforces will have to adapt to the changing tides, said experts at the recent Outsourcing in Clinical Trials New England conference.
The event, held from 23鈥�24 October, gathered experts across the clinical trial industry to discuss the evolving landscape of AI in the pharmaceutical sector. 鈥淥ur industries are terrible at adopting new technology,鈥� says Manny Lazaro, the senior vice president of clinical operations and data management at the neuroscience biotech Cerevel Therapeutics. Lazaro highlighted the falling momentum behind major clinical trends such as and the wave of eCOA and eConsent forms, but he suspected that AI would be different.
AI can be partnered with electronic medical records for recruitment, said Brian Wehrle, the vice president of R&D imaging at Clario, in a later talk. The Philadelphia, US-headquartered clinical research organisation uses AI for several aspects of its business operations. At Clario, workers use AI for clinical trials in image de-identification, and analysis of historical trial protocols amongst other uses, explained Wehrle.
Wehrle cautioned this process is not easy. The pharma sector needs to be prepared to adapt to the rapidly changing technology. 鈥淲e code something and a month later we have to change the code,鈥� he said adding, 鈥淚t鈥檚 a lot of effort to keep up with AI but it鈥檚 well worth it.鈥�
As AI becomes a staple in clinical research, Lazaro predicted that employers in the industry will start to prefer employees with more analytical skillsets who can handle larger, more numerous datasets. As the fully loaded cost of labour is the primary expense component of the majority of muti-centre clinical trials, trial sponsors and CROs will look to AI-assisted automated alternatives such as chatbots to reduce these costs, added Harry Barnett, the executive chairman at the Framingham, Massachusetts-based Lubris BioPharma.
The 16th Outsourcing in Clinical Trials New England conference was hosted by Arena International Events Group, a B2B events company owned by GlobalData, the parent company of聽Clinical Trials Arena听补苍诲听污污漫畫 Technology.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
